A Role for Cdc28/Cdk1 in Transcriptional Regulation pp. 3--6
============================================================

In budding yeast, cyclin-dependent kinases (CDKs) Kin28, Bur1 and Ctk1 regulate basal transcription by phosphorylating the CTD in RNAP II . In this issue of *Transcription*, Chymkowitch and Enserink discuss their recent findings involving CDK Cdc28 in the transcription process. Upon cell cycle entry, Cdc28 kinase activity boosts transcription of a subset of genes by directly stimulating the basal transcription machinery. The authors share their view on the kinase-dependent role of Cdc28 in the regulation of RNAP II.

On RNAP II Occupancy, mRNA Processing and Termination pp. 7--12
===============================================================

In this issue of *Transcription*, Anamika et al. discuss the role of RNAP II occupancy downstream of the 3′ end of genes and its links with termination and mRNA 3′ processing.

The Two Faces of BRD4 pp. 13--7
===============================

The bromodomain protein BRD4 links cell cycle and transcription, bookmarking active genes during mitosis and serving as a scaffold for transcription factors. Devaiah and Singer review their recent discovery that BRD4 is a RNAP II CTD kinase and discuss this novel transcriptional function and a new model in the context of current knowledge.

p300 and CBP in a Secret (Silent) Mission pp. 18--23
====================================================

Co-activators p300 and CBP are histone acetylases and central regulators of transcription in metazoans. The genomic occupancy of p300/CBP can be used to identify transcriptional enhancers. Although p300/CBP occupancy in general correlates with gene activation, they can also be found at silent genomic regions, where they do not mediate histone acetylation. Polycomb-mediated H3K27me3 is associated with repression, but does not preclude p300/CBP binding. Holmqvist and Mannervik propose that an antagonism between H3K27ac and H3K27me3 indicates that p300/CBP may be involved in switching between repressed and active chromatin states.

A Novel Mode of Tumor Suppression for BRCA1 pp. 24--8
=====================================================

Mutation in *BRCA1* accounts for half of all familial breast cancer cases. Chang and Sharan discuss recent studies that have shown that BRCA1 has a role in the epigenetic regulation of an oncogenic microRNA, revealing a novel mode of tumor suppression that is independent of its well-established role in DNA repair and cell cycle regulation.

TAF7: Traffic Controller in Transcription Initiation pp. 29--33
===============================================================

TAF7, a component of the TFIID complex, controls the first steps of transcription. It interacts with RNAP II and regulates the enzymatic activities of transcription factors that regulate transcription progression. Gegonn et al. reviews TAF7 diverse functions during transcription initiation in the context of its essential role in cell proliferation.

On RNAP II Behavior in the Presence of DSBs pp. 34--8
=====================================================

Recent studies have uncovered previously uncharacterized behavior of the RNAP II machinery in the presence of double strand breaks. Pankotai and Soutoglou now discuss how this new data contribute to our understanding of a vital mechanism that defends cells against the production of aberrant transcripts and protects cell viability.

MED23 and the Regulation of Basal Transcription pp. 39--51
==========================================================

The Mediator, a multi-subunit complex that transduces regulatory information from transcription regulators to RNAP II, plays roles in multiple stages of eukaryotic transcription, including elongation. A Research Report by Wang et al. provides mechanistic insight into how Mediator promotes RNAP II into transcription elongation. The authors demonstrate that Mediator MED23 subunit controls a basal level of transcription by recruiting elongation factor P-TEFb, via an interaction with its CDK9 subunit. The mRNA level of *Egr1*, a MED23-controlled model gene, is reduced 4--5 fold in *Med23*^−/−^ ES cells under an unstimulated condition, but *Med23*-deficiency does not alter the occupancies of RNAP II, GTFs, Mediator complex, or activator ELK1 at the *Egr1* promoter. Instead, *Med23* depletion results in a significant decrease in P-TEFb and RNAP II (Ser2P) binding at the coding region, but no changes for several other elongation regulators, such as DSIF and NELF. The authors also demonstrate that MED23 interacts with CDK9 in vivo and in vitro.
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